Steven Kelly
2023
In 2023, Steven Kelly earned a total compensation of $3.5M as Current President & Chief Executive Officer at Eleven Biotherapeutics.
Compensation breakdown
| Bonus | $301,840 |
|---|---|
| Option Awards | $2,717,517 |
| Salary | $460,833 |
| Other | $24,235 |
| Total | $3,504,425 |
Kelly received $2.7M in option awards, accounting for 78% of the total pay in 2023.
Kelly also received $301.8K in bonus, $460.8K in salary and $24.2K in other compensation.
Rankings
In 2023, Steven Kelly's compensation ranked 234th out of 2,978 executives tracked by ExecPay. In other words, Kelly earned more than 92.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 234 out of 2,978 | 92nd |
Division Manufacturing | 126 out of 1,637 | 92nd |
Major group Chemicals And Allied Products | 87 out of 906 | 90th |
Industry group Drugs | 85 out of 869 | 90th |
Industry Pharmaceutical Preparations | 54 out of 627 | 91st |
Source: SEC filing on April 29, 2024.
Kelly's colleagues
We found five more compensation records of executives who worked with Steven Kelly at Eleven Biotherapeutics in 2023.
2023
Thomas Cannell
Eleven Biotherapeutics
Chief Executive Officer
2023
Richard Morris
Eleven Biotherapeutics
Chief Financial Officer
2023
Michael Klichinsky
Eleven Biotherapeutics
Chief Scientific Officer
2023
Monica Forbes
Eleven Biotherapeutics
Chief Financial Officer
2023
Mark Sullivan
Eleven Biotherapeutics